Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: A systematic review and meta-analysis of randomized controlled clinical trials

Clinical Endocrinology

Volumn 83, Issue 3, 2015, Pages 344-351

  Grossmann, Mathis ^a,b   Hoermann, Rudolf ^a   Wittert, Gary ^c   Yeap, Bu B ^d,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e FIONA STANLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; ANDROGEN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL FUNCTION; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; BLOOD; DIABETES MELLITUS, TYPE 2; DOUBLE BLIND PROCEDURE; METABOLISM; TREATMENT OUTCOME;

ANDROGENS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84940105378     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12664     Document Type: Review

References (35)

1. Ding, E.L., Song, Y., Malik, V.S., et al,. (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 295, 1288-1299.
2. Corona, G., Monami, M., Rastrelli, G., et al,. (2010) Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology, 34, 528-540.
3. Corona, G., Monami, M., Rastrelli, G., et al,. (2011) Testosterone and metabolic syndrome: a meta-analysis study. The Journal of Sexual Medicine, 8, 272-283.
4. Laaksonen, D.E., Niskanen, L., Punnonen, K., et al,. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27, 1036-1041.
5. Bhasin, S., Jasjua, G.K., Pencina, M., et al,. (2011) Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care, 34, 2464-2470.
6. Grossmann, M., (2014) Testosterone and glucose metabolism in men: current concepts and controversies. Journal of Endocrinology, 220, R37-R55.
7. Hamilton, E.J., Gianatti, E., Strauss, B.J., et al,. (2011) Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clinical Endocrinology (Oxford), 74, 377-383.
8. Grossmann, M., (2011) Low testosterone in men with type 2 diabetes: significance and treatment. Journal of Clinical Endocrinology and Metabolism, 96, 2341-2353.
9. Rao, P.M., Kelly, D.M., &, Jones, T.H., (2013) Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nature Reviews. Endocrinology, 9, 479-493.
10. Cai, X., Tian, Y., Wu, T., et al,. (2014) Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Asian Journal of Andrology, 16, 146-152.
11. Gianatti, E.J., Dupuis, P., Hoermann, R., et al,. (2014) Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial. Diabetes Care, 37, 2098-2107.
12. Hackett, G., Cole, N., Bhartia, M., et al,. (2013) Testosterone Replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST Study. The Journal of Sexual Medicine, 11, 840-856.
13. Moher, D., Liberati, A., Tetzlaff, J., et al,. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine, 151, 264-269, W264.
14. Moher, D., Hopewell, S., Schulz, K.F., et al,. (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ, 340, c869.
15. R Core Team (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: http://wwwR-projectorg/ (accessed 7 June 2014).
16. Viechtbauer, W., (2010) Conducting meta-analyses in R with the metafor package. Journal of Statistical Software, 36, 1-48.
17. Aversa, A., Bruzziches, R., Francomano, D., et al,. (2010) Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. The Journal of Sexual Medicine, 7, 3495-3503.
18. Kapoor, D., Goodwin, E., Channer, K.S., et al,. (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 154, 899-906.
19. Gopal, R.A., Bothra, N., Acharya, S.V., et al,. (2010) Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus. Endocrine Practice, 16, 570-576.
20. Jones, T.H., Arver, S., Behre, H.M., et al,. (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care, 34, 828-837.
21. Kalinchenko, S.Y., Tishova, Y.A., Mskhalaya, G.J., et al,. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clinical Endocrinology (Oxford), 73, 602-612.
22. Wallace, T.M., Levy, J.C., &, Matthews, D.R., (2004) Use and abuse of HOMA modeling. Diabetes Care, 27, 1487-1495.
23. Giltay, E.J., Tishova, Y.A., Mskhalaya, G.J., et al,. (2010) Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. The Journal of Sexual Medicine, 7, 2572-2582.
24. Hackett, G., Cole, N., Bhartia, M., et al,. (2013) Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. The Journal of Sexual Medicine, 10, 1612-1627.
25. Gianatti, E.J., Dupuis, P., Hoermann, R., et al,. (2014) Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 99, 3821-3828.
26. Unpublished accessed at Available from: http://www.solvaypharmaceuticals.com/static/wma/pdf/1/3/4/4/2/S176.2.101.pdf (accessed 28 May 2014).
27. Singh, A.B., Hsia, S., Alaupovic, P., et al,. (2002) The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. Journal of Clinical Endocrinology and Metabolism, 87, 136-143.
28. Grossmann, M., Thomas, M.C., Panagiotopoulos, S., et al,. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. Journal of Clinical Endocrinology and Metabolism, 93, 1834-1840.
29. Isidori, A.M., Giannetta, E., Greco, E.A., et al,. (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology (Oxford), 63, 280-293.
30. Juang, P.S., Peng, S., Allehmazedeh, K., et al,. (2013) Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial. The Journal of Sexual Medicine, 11, 563-573.
31. Woodhouse, L.J., Gupta, N., Bhasin, M., et al,. (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. Journal of Clinical Endocrinology and Metabolism, 89, 718-726.
32. Haider, A., Yassin, A., Doros, G., et al,. (2014) Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes. International Journal of Endocrinology, 2014, 683515.
33. Fernandez-Balsells, M.M., Murad, M.H., Lane, M., et al,. (2010) Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 95, 2560-2575.
34. Snyder, P.J., Peachey, H., Berlin, J.A., et al,. (2000) Effects of testosterone replacement in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 85, 2670-2677.
35. Endocrine Society Statement (2014) The Risk of Cardiovascular Events in Men Receiving Testosterone Therapy. http://www.endocrine.org/~/media/endosociety/Files/ Advocacy and Outreach/Position Statements/Other Statements/The Risk of Cardiovascular Events in Men Receiving Testosterone Therapy.pdf (accessed 28 May 2014)